Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
Journal of Clinical Medicine · 10.03.2025 · 14 (6) · 1856
DOI: 10.3390/jcm14061856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.03.2025. Verfasst von Morten Karsdal und 46 weiteren Autor:innen. Beteiligte Einrichtung: Nordic Bioscience, 2730 Herlev, Denmark. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The extracellular matrix (ECM) is the common denominator of more than 50 chronic diseases. Some of these chronic pathologies lead to enhanced tissue formation and deposition, whereas others are associated with increased tissue degradation, and some exhibit a combination of both, leading to severe tissue alterations. To develop effective therapies for diseases affecting the lung, liver, kidney, skin, intestine, musculoskeletal system, heart, and solid tumors, we need to modulate the ECM’s composition to restore its organization and function. Across diverse organ diseases, there are common denominators and distinguishing factors in this fibroinflammatory axis, which may be used to foster new insights into drug development across disease indications. The 2nd Extracellular Matrix Pharmacology Congress took place in Copenhagen, Denmark, from 17 to 19 June 2024 and was hosted by the International Society of Extracellular Matrix Pharmacology. The event was attended by 450 participants from 35 countries, among whom were prominent scientists who brought together state-of-the-art research on organ diseases and asked important questions to facilitate drug development. We highlight key aspects of the ECM in the liver, kidney, skin, intestine, musculoskeletal system, lungs, and solid tumors to advance our understanding of the ECM and its central targets in drug development. We also highlight key advances in the tools and technology that enable this drug development, thereby supporting the ECM.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nordic Bioscience, 2730 Herlev, Denmark.
- Garvan Institute of Medical Research, Sydney 2010, Australia.
- School of Clinical Medicine, St Vincent's Clinical Campus, UNSW Medicine & Health, UNSW, Sydney 2010, Australia.
- Margaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, NIHR Imperial Biomedical Research Centre, Imperial College London, London SW7 2AZ, UK.
- Gubra, 2970 Hørsholm, Denmark.
- Global Drug Discovery, Novo Nordisk, 2760 Maaloev, Denmark.
ORCID-Profile: Morten Karsdal, Thomas R Cox, Henrik H Hansen, Darcey Black, Federica Genovese, Alexander Eckersley, Andrea Heinz, Alexander Nyström, Signe Holm Nielsen, Lucas Bennink, Anne-Christine Bay-Jensen, Dana E Orange, Scott Friedman, Lee Borthwick, Mark Skarsfeldt, Paresh Thakker, Darren Ruane, Dovile Sinkeviciute, Christian Thudium, Michael Cooreman, Andre Broermann, Diana Julie Leeming, Ali Mobasheri, Sylvie Ricard-Blum
Zitieren
APA
Karsdal, M., Cox, T. R., Parker, A. L., Willumsen, N., Sand, J. M. B., Jenkins, G., Hansen, H. H., Oldenburger, A., Geillinger-Kaestle, K. E., Larsen, A. T., Black, D., Genovese, F., Eckersley, A., Heinz, A., Nyström, A., Holm Nielsen, S., Bennink, L., Johannsson, L., Bay-Jensen, A. C., …, & Ricard-Blum, S. (2025). Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics. Journal of Clinical Medicine, 14(6), 1856. https://doi.org/10.3390/jcm14061856
Vancouver
Karsdal M, Cox TR, Parker AL, Willumsen N, Sand JMB, Jenkins G, et al. Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics. Journal of Clinical Medicine. 2025;14(6):1856. doi:10.3390/jcm14061856
BibTeX
@article{Karsdal2025,
author = {Karsdal, Morten and Cox, Thomas R and Parker, Amelia L and Willumsen, Nicholas and Sand, Jannie Marie Bülow and Jenkins, Gisli and Hansen, Henrik H and Oldenburger, Anouk and Geillinger-Kaestle, Kerstin E and Larsen, Anna Thorsø and Black, Darcey and Genovese, Federica and Eckersley, Alexander and Heinz, Andrea and Nyström, Alexander and Holm Nielsen, Signe and Bennink, Lucas and Johannsson, Lars and Bay-Jensen, Anne-Christine and Orange, Dana E and Friedman, Scott and Røpke, Mads and Fiore, Vincent and Schuppan, Detlef and Rieder, Florian and Simona, Benjamin and Borthwick, Lee and Skarsfeldt, Mark and Wennbo, Haakan and Thakker, Paresh and Stoffel, Ruedi and Clarke, Graham W and Kalluri, Raghu and Ruane, Darren and Zannad, Faiez and Mortensen, Joachim Høg and Sinkeviciute, Dovile and Sundberg, Fred and Coseno, Molly and Thudium, Christian and Croft, Adam P and Khanna, Dinesh and Cooreman, Michael and Broermann, Andre and Leeming, Diana Julie and Mobasheri, Ali and Ricard-Blum, Sylvie},
title = {Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {6},
pages = {1856},
doi = {10.3390/jcm14061856}
}
EUVIMED